[Basic and clinical trials of aztreonam in the field of pediatrics].

Author: FujimotoT, KawakamiA, KogaT, MotohiroT, NishiyamaT, SakataY, ShimadaY, TanakaK, TominagaK, TomitaN

Paper Details 
Original Abstract of the Article :
Serum and urinary concentrations and recovery rates of aztreonam (SQ26,776, AZT), a newly developed antibiotic, were studied for a total of 20 pediatric cases by one-shot intravenous injections of 10, 20 and 40 mg/kg to 3, 4 and 3 cases, respectively, and by intravenous drip infusion of 10, 20 and 4...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/3912525

データ提供:米国国立医学図書館(NLM)

Aztreonam: A Promising Antibiotic for Pediatric Infections

Pediatric infections can be challenging to treat, requiring medications that are both effective and safe for young patients. This study investigates the pharmacokinetics and clinical effectiveness of aztreonam, a new antibiotic, in pediatric patients. The researchers examined the serum and urinary concentrations of aztreonam in children after intravenous administration, evaluating its safety and efficacy. Their findings suggest that aztreonam is well-tolerated by children and demonstrates promising antibacterial activity against a range of bacterial infections, including pneumonia, otitis media, and urinary tract infections. This research highlights the potential of aztreonam as a valuable therapeutic option for treating pediatric infections.

Expanding the Antimicrobial Arsenal

The study's findings suggest that aztreonam could be a valuable addition to the antimicrobial arsenal for treating pediatric infections. The researchers' data show that aztreonam is effective against a range of bacteria and well-tolerated by young patients. This research opens up new possibilities for treating pediatric infections and improving patient outcomes.

Prioritizing Pediatric Health: A Shared Responsibility

Pediatric health is a priority, and researchers are constantly working to develop safer and more effective treatments for children. This study highlights the importance of ongoing research and development in the field of pediatric infectious diseases. By understanding the unique needs of young patients and exploring new therapeutic options, we can work towards a healthier future for children.

Dr.Camel's Conclusion

Just as a camel's journey across the desert requires careful preparation and planning, treating pediatric infections requires a thoughtful approach. This research highlights the potential of aztreonam to provide effective and safe treatment for children, offering hope for improved outcomes and a brighter future for young patients.

Date :
  1. Date Completed 1986-04-21
  2. Date Revised 2016-11-16
Further Info :

Pubmed ID

3912525

DOI: Digital Object Identifier

3912525

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.